期刊文献+

膈肌病灶切除术在晚期卵巢癌患者处理中的价值 被引量:5

The Application of Diaphragm Resection in Late Stage of Ovarian Cancer
下载PDF
导出
摘要 卵巢癌是致死率最高的妇科恶性肿瘤,由于缺乏早期诊断手段,往往发现时已为晚期。手术是治疗卵巢癌的主要方法,理想的卵巢肿瘤细胞减灭术是影响患者生存率的独立因素。晚期卵巢癌通常累及上腹腔,膈肌转移更是很常见,发生率约为18%~42%,而这个部位的转移也很难处理,常导致不理想的肿瘤细胞减灭术,降低患者生存率,影响预后。随着手术技巧的提高,近年来卵巢癌的膈肌病灶切除术得到一定的发展,膈肌转移病灶不是满意的卵巢肿瘤细胞减灭术的障碍,膈肌病灶切除术是减瘤术必要的手术步骤。综述膈肌病灶切除术在卵巢癌肿瘤细胞减灭术中的应用。 Ovarian cancer is gynecological malignancy with the highest death rate from the disease.Due to the insidious nature of ovarian cancer, the majority of patients at time of diagnosis have progressed to stage Ⅲ or stage Ⅳ disease. Surgery is the main treatment of ovarian cancer, optimal cytoreduction is the independent factors affecting prognosis. Patients with advanced ovarian cancer often have disease invading the upper abdomen, most commonly, the diaphragm,about18%-42%. And the metastasis is also difficult to managed,leads to suboptimal eytoreduetion with reducing survival rate o A number of surgical techniques are available to effect cytoreduction of diaphragmatic involvement by ovarian cancer. Diaphragm metastasis is not abstacle of optimal cytoreduction, and diaphragm resection is necessary procedure of cytoreduction. This Article is to describe the application of the technology in ovarian cancer.
作者 卢艳 姚德生
出处 《国际妇产科学杂志》 CAS 2013年第1期67-70,共4页 Journal of International Obstetrics and Gynecology
关键词 卵巢肿瘤 肿瘤分期 治疗 肿瘤转移 Ovarian neoplasms Carcinoma Neoplasm staging Therapy Neoplasm metastasis
  • 相关文献

参考文献23

  • 1Eisenkop SM, Spirtos NM, Lin WC. "Optimal"eytoreduetion for advanced epithelial ovarian cancer: a commentary [Jl. Gynecol Oncol, 2006,103 ( 1 ):329-335.
  • 2Jemal A, Bray F, Center MM, et al. Global cancer statistics [J]. CA Cancer J Clin, 2011,61 (2) :69-90.
  • 3Cliby W, Dowdy S, Feitoza SS, et al. Diaphragm resection for ovarian cancer: technique and short-term complications [J]. Gynecol Oncol, 2004,94 ( 3 ):655-660.
  • 4Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010 [J]. CA Cancer J Clin, 2010,60 ( 5 ):277-300.
  • 5Devolder K, Amant F, Neven P, et al. Role of diaphragmatic surgery in 69 patients with ovarian carcinoma [J]. Int J Gynecol Cancer, 2008,18 (2):363-368.
  • 6Fanfani F, Fagotti A, Gallotta V, et al. Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery [ J ]. Gynecol Oncol, 201 O, 116 (3) :497-501.
  • 7Eisenhauer EL, D'Angelica MI, Abu-Rustum NR, et al. Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced mullerian cancer [J]. Gynecol Oncol, 2006,103 (3):871-877.
  • 8Tsolakidis D, Amant F, Van Gorp T, et al. Diaphragmatic surgery during primary debulking in 89 patients with stage Ⅲ B-Ⅳ epithe- lial ovarian cancer[J]. Gynecol Onco1,2010, 1 16(3 ):489-496.
  • 9Dowdy SC, Loewen RT, Aletti G, et al. Assessment of outcomes and morbidity following diaphragmatic peritonectomy for women with ovarian carcinoma [ J ]. Gynecol Oncol, 2008,109 ( 2 ) :303-307.
  • 10Chereau E, Rouzier R, Gouy S, et al. Morbidity of diaphragmatic surgery for advanced ovarian cancer: retrospective study of 148 cases [ J ]. Eur J Surg Oncol, 2011,37 (2): 175-180.

同被引文献17

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部